Full Press Release Details
Third Quarter total revenue expected
to be in the range of $8.4 million to $8.5 million, an increase of approximately 6 - 7% over the same period last year.
Mont. - October 14, 2014, - Bacterin International
Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications,
today announced preliminary, unaudited revenue for the third quarter of 2014.
Company is expecting total revenue for the third quarter of 2014 to be in the range of $8.4 million to $8.5 million, representing
an increase of 6 - 7%
when compared to $7.9 million reported for the third quarter of 2013.
marks four straight quarters of year-over-year revenue growth," said
Bacterin CEO Dan Goldberger. "After meeting our goal of stabilizing the business by the end of 2013, we began investing in
new products and strengthening our sales force. We are now starting to realize the benefits of these investments and we expect
to see our revenue accelerate by the end of 2015."
The quarterly financial results included in this release were
calculated prior to the completion of a review by Bacterin's external auditors and are therefore subject to adjustment.
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE MKT: BONE) develops,
manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the
growth factors in human allografts to promote bone growth, subchondral repair and dermal growth. These products are used in a variety
of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery,
promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.
Bacterin's Medical Device division develops and licenses coatings
for various medical device applications. For further information, please visit www.bacterin.com.
Important Cautions Regarding Forward-looking Statements
This news release contains certain disclosures that may be deemed
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to significant
risks and uncertainties. Forward-looking statements include statements that are predictive in nature, that depend upon or refer
to future events or conditions, or that include words such as "continue," "efforts," "expects," "anticipates,"
"intends," "plans," "believes," "estimates," "projects," "forecasts,"
"strategy," "will," "goal," "target," "prospects," "potential," "optimistic,"
"confident," "likely," "probable" or similar expressions or the negative thereof. Statements of historical
fact also may be deemed to be forward-looking statements. We caution that these statements by their nature involve risks and uncertainties,
and actual results may differ materially depending on a variety of important factors, including, among others: the ability of the
Company's sales force to achieve expected results, the Company's ability to meet its existing and anticipated contractual
obligations, including financial covenant and other obligations contained in the Company's secured lending facility; the
Company's ability to manage cash flow; the Company's ability to obtain shareholder approval of financing transactions;
the Company's ability to develop, market, sell and distribute desirable applications, products and services and to protect its
intellectual property; the ability of the Company's customers to pay and the timeliness of such payments; the Company's ability
to obtain financing as and when needed; changes in consumer demands and preferences; the Company's ability to attract and retain
management and employees with appropriate skills and expertise; the Company's ability to successfully conclude government
investigations; the impact of changes in market, legal and regulatory conditions and in the applicable business environment, including
actions of competitors; the Company's ability to remain listed on the NYSE MKT; and other factors. Additional risk factors
are listed in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q under the heading "Risk Factors."
The Company undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances
after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.